[AI Pharmaceutical Company Iambic, Backed by Nvidia, Raises $150 Million in U.S. IPO] According to Deep Tide TechFlow, on October 15, Bloomberg reported that Iambic Therapeutics Inc., a clinical-stage cancer drug development and technology company backed by Nvidia Corp., raised $150 million through its initial public offering (IPO) in the United States. In a statement released on Wednesday, the company announced that it issued approximately 9.38 million shares at a price of $16 per share, which is in the middle of the previously guided range of $15 to $17 per share.